Why the study?
Does pretreatment with proteinase inhibitor prevent pulmonary hypertension caused by vasoactive substances in a dog model of pulmonary embolism?
Does pretreatment with proteinase inhibitor prevent pulmonary hypertension caused by vasoactive substances in a dog model of pulmonary embolism?
Stasis of vasoactive substances may contribute to the humoral component of pulmonary hypertension in pulmonary embolism, which can be partially blocked by proteinase inhibitors.
Answers are grounded in this paper and cite their sources.
May partially attenuate humoral PH in experimental PE; leaves open clinical translation of proteinase inhibitors.
Pulmonary and systemic vascular responses to vasoactive substances, injected distal to a pulmonary artery balloon, were studied in dogs. Extract of lung homogenate, serotonin, or histamine injected in the pulmonary artery distal to an obstruction caused pulmonary hypertension. If the animal was pretreated with proteinase inhibitor, the pulmonary vascular reactivity to extract of lung homogenate and serotonin was obviated. This was not true of the reaction due to histamine. These findings suggest that stasis of vasoactive substances may be an important consideration in the concept of a humoral component in pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
William M. Hamilton (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: